BBR Partners »

Centessa Pharmaceuticals shares owned by BBR Partners

Quarter-by-quarter ownership of Centessa Pharmaceuticals (CNTA) shares owned by BBR Partners from 13F filings

Historical chart of BBR Partners investment in Centessa Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Centessa Pharmaceuticals held by BBR Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Centessa Pharmaceuticals by BBR Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $260k 6.6k 39.72

More positions owned by BBR Partners

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ab Active Etfs Intl Low Volatlt (ILOW)
Ishares Tr Core S&p500 Etf (IVV)
United Parcel Service CL B (UPS)
Apple (AAPL)
Exchange Listed Fds Tr Long Pond Real E (LPRE)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Alphabet Cap Stk Cl A (GOOGL)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard World Fds Inf Tech Etf (VGT)
Microsoft Corporation (MSFT)
Philip Morris International (PM)
Kkr & Co Cl A (KKR)
Spdr Gold Trust Gold Shs (GLD)

View all positions for BBR Partners

Top funds holding Centessa Pharmaceuticals

Medicxi Ventures Management
venBio Select Advisor
Adage Capital Partners GP
FMR
Pentwater Capital Management
EcoR1 Capital
General Atlantic
Farallon Capital Management
Perceptive Advisors
Capital World Investors
TCG Crossover Management
Morgan Stanley
Siren
Paradigm Biocapital Advisors
Henderson Group

View all funds holding Centessa Pharmaceuticals